Multiple Myeloma
From the Journals
Steroids can be stopped in some older multiple myeloma patients
News
First CAR T-cell therapy for multiple myeloma: Abecma
“The results of this trial represent a true turning point in the treatment of this disease.”
Feature
FDA scrutinizes cancer therapies granted accelerated approval
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
From the Journals
‘Phenomenal’ results with CAR T cells in R/R multiple myeloma
Conference Coverage
Steroid complications in GVHD common, boost costs of care
Conference Coverage
Chronic GVHD therapies offer hope for treating refractory disease
From the Journals
Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplant
But only if caregivers are equipped for outpatient care.
Conference Coverage
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myeloma
From the Journals
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Conference Coverage
Five-minute SC injection of daratumumab in RRMM
“The appeal of subcutaneous daratumumab is the 5 minutes it needs for administering, cutting down considerable on ‘chair/clinic’ time.”